Nath Bio-Genes Announces 33rd AGM on Sep 24, 2026; Declares ₹2 Dividend
Nath Bio-Genes will hold its 33rd AGM on September 24, 2026, via VC/OAVM. The company recommended a final dividend of ₹2 per equity share for FY 2025-26. Key agenda items include adopting financial statements, re-appointing directors, and revising the MD's remuneration to ₹1.44 crore annually. E-voting is available from Sep 21-23, 2026.
The announcement concerns standard corporate governance procedures like the AGM, dividend declaration, and director re-appointments. The remuneration increase for the MD is a material financial change, but the dividend is a standard payout. The impact is moderate as it concerns routine shareholder matters.
The announcement is a routine corporate communication regarding the AGM, dividend declaration, and director appointments. While the dividend and remuneration revision are positive for stakeholders, the overall nature of the announcement is procedural.
Nath Bio-Genes (India) Limited has announced the details of its 33rd Annual General Meeting (AGM), scheduled to be held on Thursday, September 24, 2026, at 11:00 a.m. through Video Conferencing/Other Audio Visual Means (VC/OAVM).
The company will also be submitting its Integrated Annual Report for the financial year 2025-26 to the shareholders electronically. A final dividend of ₹2 per equity share of face value ₹10 each for the financial year ended March 31, 2026, has been recommended by the Board of Directors for approval at the AGM.
Key agenda items for the AGM include the adoption of audited standalone and consolidated financial statements for FY 2025-26, declaration of the final dividend, re-appointment of Mrs. Jeevanlata Kagliwal as a Director retiring by rotation, and the re-appointment of Mr. Hitesh Rajnikant Purohit as an Independent Director for a second term of five years from March 30, 2027, to March 29, 2032. Additionally, the revision in remuneration of Mr. Satish Laxminarayan Kagliwal, Managing Director, effective from January 1, 2026, will be presented for approval. His annual salary will be revised to ₹1,44,00,000 from ₹66,00,000.
The cut-off date for determining voting rights is Friday, September 11, 2026. The remote e-voting period will commence on Monday, September 21, 2026, at 9:00 a.m. and conclude on Wednesday, September 23, 2026, at 5:00 p.m. The Register of Members and Share Transfer Books will be closed from September 20, 2026, to September 24, 2026.
A plain-language summary of a public exchange filing by Nath Bio-Genes (India) Limited. Read the original for the full detail.